Apolipoprotein B beyond LDL-cholesterol in predicting Atherosclerotic Cardiovascular Disease risk in high-risk populations
Despite achieving target low-density lipoprotein cholesterol (LDL-C) levels, many individuals remain at elevated atherosclerotic cardiovascular disease (ASCVD) risk. Apolipoprotein B (ApoB), reflecting atherogenic particle number instead of cholesterol mass, may better capture this residual risk. To invest...